- Patent Title: Intralesional (Intratumoral) dinitrochlorobenzene and associated compounds coadministered with checkpoint inhibitors for cancer treatment including treatment of metastatic cutaneous cancers
-
Application No.: US15442615Application Date: 2017-02-24
-
Publication No.: US10166290B2Publication Date: 2019-01-01
- Inventor: Max H. Cohen
- Applicant: Max H. Cohen
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/04 ; A61K39/00 ; A61K47/12 ; A61K47/44 ; A61K39/395
Abstract:
Inventor seeks patents related to the use in solid cancer patients of substances, (including, for example, dinitrohalogenated compounds) injected into tumor nodules in association with treatment with one or more checkpoint inhibitors that are administered before, during or after the intralesional (intratumoral) injection or injections.
Public/Granted literature
Information query
